A large prospective cohort study using UK Biobank data found that a higher FIB-4 index was independently associated with an increased risk of incident COPD.
Abstract
Background
The Fibrosis-4 (FIB-4) index, a noninvasive hepatic fibrosis marker reflecting systemic inflammation and metabolic dysfunction, is associated with adverse outcomes in established chronic obstructive pulmonary disease (COPD). However, its ability to predict incident COPD in the general population remains unknown.
Methods
We conducted a prospective cohort study using UK Biobank data from 444,376 participants without prevalent COPD at baseline. The FIB-4 index was calculated from age, aspartate aminotransferase, alanine aminotransferase, and platelet count. The primary outcome is incident COPD. Cox proportional-hazards models were used to estimate hazard ratios (HRs) for incident COPD across FIB-4 categories (low, intermediate, high).
Results
During a median follow-up of 14.1 years, 18,515 incident COPD events occurred. Higher FIB-4 was associated with a graded increase in COPD risk. In the fully adjusted model, the HRs for the intermediate and high FIB-4 categories were 1.48 (95% confidence interval [CI], 1.43 to 1.53) and 1.72 (95% CI, 1.57 to 1.88), respectively, as compared with the low category. When FIB-4 was analyzed as a continuous variable via restricted cubic splines, a positive graded association with COPD risk was observed with significant non-linearity (P for non-linearity <0.001). Results were consistent in both sexes and across sensitivity analyses, including exclusion of participants with hypertension, diabetes, or liver disease and exclusion of early events. Competing-risk analysis with death as a competing event yielded similar findings.
Conclusions
In this large prospective cohort study, we found that a higher FIB-4 index was independently associated with an increased risk of incident COPD.
Fibrotic interstitial lung disease (fILD) is often diagnosed late and can be difficult to recognise in people with common respiratory or cardiac long-term conditions. We examined whether baseline routine blood-test profiles and leucocyte telomere length (LTL) identified groups at higher risk of subsequent hospital-...
G. Lough, L. Wain, A. Meffen et al.· ERJ Open Research· 0 citations
In a primary care population, statin prescriptions were associated with a lower risk of fibrosis progression and SLD in patients with chronic liver disease.
Nicholas P. Smith, A. Schreiner, Jing-Wen Zhang et al.· Clinics And Research in Hepa...· 0 citations
Objective: Advanced fibrosis is the best predictor of future severe liver outcomes in patients with metabolic dysfunction associated steatotic liver disease (MASLD). Our study aims to determine the association between cardiovascular disease (CVD) with time to a high-risk Fibrosis-4 Index (FIB-4) in patients with low-ri...
Myra Quiroga, K. Anderson, Jing-Wen Zhang et al.· Livers· 0 citations
In COPD patients, the CALLY index exhibits a significant L-shaped association with incident depression risk, characterized by a pronounced protective effect below the identified threshold and a risk plateau above it, suggesting that the CALLY index may serve as a clinically accessible tool for depression risk stratific...
Yu-Shan Shi, Xian-Hai Chen, Yan Wang· Frontiers in Medicine· 0 citations
Objective Chronic obstructive pulmonary disease (COPD) and panvascular disease (PD) are often driven by shared risk factors. We aimed to investigate the longitudinal association of triglyceride-glucose (TyG) index with incidence of COPD, PD, and their multimorbidity. Methods Our study used data from the UK Biobank, a p...
Shuo Zhang, Xiao-Tian Li, Jia-Jing Li et al.· Frontiers in Cardiovascular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.